JPWO2023111148A5 - - Google Patents

Info

Publication number
JPWO2023111148A5
JPWO2023111148A5 JP2024534474A JP2024534474A JPWO2023111148A5 JP WO2023111148 A5 JPWO2023111148 A5 JP WO2023111148A5 JP 2024534474 A JP2024534474 A JP 2024534474A JP 2024534474 A JP2024534474 A JP 2024534474A JP WO2023111148 A5 JPWO2023111148 A5 JP WO2023111148A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534474A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546763A (ja
JP2024546763A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/086084 external-priority patent/WO2023111148A1/en
Publication of JP2024546763A publication Critical patent/JP2024546763A/ja
Publication of JP2024546763A5 publication Critical patent/JP2024546763A5/ja
Publication of JPWO2023111148A5 publication Critical patent/JPWO2023111148A5/ja
Pending legal-status Critical Current

Links

JP2024534474A 2021-12-16 2022-12-15 イヌインターロイキン-31受容体アルファiに対するイヌ化抗体 Pending JP2024546763A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163290256P 2021-12-16 2021-12-16
US202163290259P 2021-12-16 2021-12-16
US63/290,259 2021-12-16
US63/290,256 2021-12-16
US202263341443P 2022-05-13 2022-05-13
US63/341,443 2022-05-13
PCT/EP2022/086084 WO2023111148A1 (en) 2021-12-16 2022-12-15 Caninized antibodies to canine interleukin-31 receptor alpha 1

Publications (3)

Publication Number Publication Date
JP2024546763A JP2024546763A (ja) 2024-12-26
JP2024546763A5 JP2024546763A5 (https=) 2025-12-19
JPWO2023111148A5 true JPWO2023111148A5 (https=) 2025-12-19

Family

ID=84923386

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024534465A Pending JP2024546759A (ja) 2021-12-16 2022-12-15 イヌインターロイキン-31受容体アルファiiに対するイヌ化抗体
JP2024534474A Pending JP2024546763A (ja) 2021-12-16 2022-12-15 イヌインターロイキン-31受容体アルファiに対するイヌ化抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024534465A Pending JP2024546759A (ja) 2021-12-16 2022-12-15 イヌインターロイキン-31受容体アルファiiに対するイヌ化抗体

Country Status (7)

Country Link
US (2) US20250340653A1 (https=)
EP (2) EP4448571A1 (https=)
JP (2) JP2024546759A (https=)
AU (2) AU2022409610A1 (https=)
CA (2) CA3239826A1 (https=)
MX (2) MX2024007090A (https=)
WO (2) WO2023111148A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116744917A (zh) 2020-09-04 2023-09-12 礼蓝美国公司 适口调配物
WO2025174998A1 (en) * 2024-02-13 2025-08-21 Invetx, Inc. Anti-il-31ra antibodies and uses thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
AU584417B2 (en) 1985-04-01 1989-05-25 Lonza Group Ag Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
ES2443022T3 (es) 2005-08-12 2014-02-17 Merck Frosst Canada Inc. Derivados de indol como antagonistas del receptor CRTH2
JP4884570B2 (ja) 2008-08-20 2012-02-29 ファイザー・インク ピロロ[2,3−d]ピリミジン化合物
AU2009295229B2 (en) 2008-09-22 2014-02-27 Merck Canada Inc. Indole derivatives as CRTH2 receptor antagonists
AU2009295231A1 (en) 2008-09-22 2010-03-25 Merck Canada Inc. Azaindole derivatives as CRTH2 receptor antagonists
WO2011075517A1 (en) 2009-12-17 2011-06-23 Merck Sharp & Dohme Corp. Aminopyrimidines as syk inhibitors
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
JP6701079B2 (ja) 2013-12-20 2020-05-27 インターベット インターナショナル ベー. フェー. ヒトpd−1に対するイヌ化マウス抗体
WO2018073185A1 (en) * 2016-10-17 2018-04-26 Vetoquinol Sa Modified antibody constant region
AU2017376398B2 (en) 2016-12-14 2021-07-15 Intervet International B.V. Aminopyrazoles as selective janus kinase inhibitors
WO2018156180A1 (en) 2017-02-24 2018-08-30 Kindred Biosciences, Inc. Anti-il31 antibodies for veterinary use
CN113227134A (zh) * 2018-12-05 2021-08-06 株式会社梅花治疗 抗体的Fc区变体
US11542333B2 (en) * 2019-01-03 2023-01-03 Invetx, Inc. Compositions for increasing half-life of a therapeutic agent in canines and methods of use
CN110563844A (zh) * 2019-09-04 2019-12-13 华中农业大学 一种抗犬白介素31受体的多克隆抗体及其应用
MX2022007636A (es) * 2019-12-20 2022-07-19 Intervet Int Bv Anticuerpos biespecificos caninizados y pares de union biespecificos para el tratamiento contra dermatitis atopica.

Similar Documents

Publication Publication Date Title
JP2022177090A5 (https=)
JP2022191383A5 (https=)
JP2024109678A5 (https=)
JP2021524267A5 (https=)
JP2021521843A5 (https=)
RU2020130795A (ru) Нейтрализующие антитела к env вич-1 и их применение
JP2021524478A5 (https=)
CN115461368A (zh) 抗人白细胞介素-4受体α抗体及其制备方法和应用
JP2023093753A5 (https=)
JP2025183307A5 (https=)
JP2016520619A5 (https=)
JPWO2019209995A5 (https=)
CN110869390A (zh) 抗pd-l1抗体及其用途
JPWO2020011966A5 (https=)
JPWO2022256563A5 (https=)
CN106565840A (zh) 抗乙肝表面抗原的抗体及其用途
JPWO2020004490A5 (https=)
JP2026510999A (ja) Cd19/cd38多重特異性抗体
JPWO2020011973A5 (https=)
JPWO2022044573A5 (https=)
IL310419A (en) Human interleukin-4 receptor alpha antibodies
JP2019518473A5 (https=)
CN115315442A (zh) Sars-cov-2抗体及其应用
RU2016117140A (ru) Триспецифические антитела против il-17a, il-17f и другой провоспалительной молекулы
IL277899B2 (en) Methods and preparations for treating yellow fever